Orsobio, Inc
Clinical trials sponsored by Orsobio, Inc, explained in plain language.
-
New drug enters human testing, aims to tackle obesity and diabetes
Disease control Recruiting nowThis is an early-stage study to test the safety and how the body processes a new drug called TLC 6740. It will first be given to healthy volunteers to check for side effects. Later, it will be tested in people with obesity, some of whom also have type 2 diabetes, to see if it mig…
Phase: PHASE1 • Sponsor: OrsoBio, Inc • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
First human tests begin for experimental drug TLC-1180
Knowledge-focused Recruiting nowThis is a very early, first-in-human study to check the safety and basic effects of a new drug called TLC-1180. It will involve healthy volunteers to see how their bodies handle the drug and what side effects might occur. The study will test different doses and a tablet form, inc…
Phase: PHASE1 • Sponsor: OrsoBio, Inc • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC